MARKET

LNTH

LNTH

Lantheus Holding
NASDAQ
79.52
-2.22
-2.72%
After Hours: 79.78 +0.26 +0.33% 17:52 05/12 EDT
OPEN
83.01
PREV CLOSE
81.74
HIGH
83.60
LOW
78.61
VOLUME
2.17M
TURNOVER
--
52 WEEK HIGH
126.89
52 WEEK LOW
75.00
MARKET CAP
5.50B
P/E (TTM)
22.57
1D
5D
1M
3M
1Y
5Y
1D
Leerink Partners Reaffirms Their Buy Rating on Lantheus (LNTH)
TipRanks · 9h ago
Weekly Report: what happened at LNTH last week (0505-0509)?
Weekly Report · 11h ago
Healthcare stocks that could be poised for a rebound
Seeking Alpha · 3d ago
Lantheus price target lowered to $120 from $134 at JonesResearch
TipRanks · 4d ago
Lantheus Holdings Price Target Cut to $117.00/Share From $127.00 by Truist Securities
Dow Jones · 4d ago
Lantheus Holdings Is Maintained at Buy by Truist Securities
Dow Jones · 4d ago
Truist Securities Maintains Buy on Lantheus Holdings, Lowers Price Target to $117
Benzinga · 4d ago
Lantheus: Strategic Growth Potential and Market Positioning Justify Buy Rating Despite Challenges
TipRanks · 4d ago
More
About LNTH
More
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. It classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, others. Its OCTEVY is a registrational-stage positron emission tomography (PET) diagnostic imaging agent targeting neuroendocrine tumors.
Recently
Symbol
Price
%Change

Webull offers Lantheus Holdings Inc stock information, including NASDAQ: LNTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LNTH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LNTH stock methods without spending real money on the virtual paper trading platform.